Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
545 participants
OBSERVATIONAL
2011-12-31
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HBV Vaccination in HIV-infected Adults
NCT03212911
Immunity to Hepatitis B Vaccine
NCT03083158
Duration of Long-term Immunity After Hepatitis B Virus Immunization
NCT01182311
Hepatitis B Vaccine Clinical Trial
NCT00000583
Adolescents' Response to Hepatitis B Vaccine Booster Dose
NCT01341275
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study is designed to determine HBV vaccination policy among new HCWs in the IDF, who were vaccinated during infancy. This population was recruited to the IDF since the second half of 2010. Therefore, it is necessary to conduct this study on new HCWs that will be receiving the routine HBV vaccination and that will be at risk for HBV infection in the future due to their occupation in the army (HCWs, etc).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
personnel in medical training - COURSE 1
No interventions assigned to this group
personnel in medical training - COURSE 2
No interventions assigned to this group
personnel in medical training - COURSE 3
No interventions assigned to this group
personnel in medical training - COURSE 4
No interventions assigned to this group
personnel in medical training - COURSE 5
No interventions assigned to this group
personnel in medical training - COURSE 6
No interventions assigned to this group
personnel in medical training - COURSE 7
No interventions assigned to this group
personnel in medical training - COURSE 8
No interventions assigned to this group
personnel in medical training - COURSE 9
No interventions assigned to this group
personnel in medical training - COURSE 10
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Soldiers taking part in a medical training course
3. Soldiers that signed an informed consent form
Exclusion Criteria
2. Soldiers with previous known infection with HBV
3. Soldiers with documented evidence of immunity against HBV
4. Soldiers that refuse to participate in the study
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical Corps, Israel Defense Force
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Hartal, MD
Role: PRINCIPAL_INVESTIGATOR
International Diabetes Federation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Israeli Defense Forces
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IDF 1047-2011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.